BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36737599)

  • 1. The E3 ligase RNF5 restricts SARS-CoV-2 replication by targeting its envelope protein for degradation.
    Li Z; Hao P; Zhao Z; Gao W; Huan C; Li L; Chen X; Wang H; Jin N; Luo ZQ; Li C; Zhang W
    Signal Transduct Target Ther; 2023 Feb; 8(1):53. PubMed ID: 36737599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The E3 Ubiquitin Ligase RNF5 Facilitates SARS-CoV-2 Membrane Protein-Mediated Virion Release.
    Yuan Z; Hu B; Xiao H; Tan X; Li Y; Tang K; Zhang Y; Cai K; Ding B
    mBio; 2021 Feb; 13(1):e0316821. PubMed ID: 35100873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRL4B E3 ligase recruited by PRPF19 inhibits SARS-CoV-2 infection by targeting ORF6 for ubiquitin-dependent degradation.
    Zhang L; Hao P; Chen X; Lv S; Gao W; Li C; Li Z; Zhang W
    mBio; 2024 Feb; 15(2):e0307123. PubMed ID: 38265236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple E3 ligases act as antiviral factors against SARS-CoV-2 via inducing the ubiquitination and degradation of ORF9b.
    Yu M; Li J; Gao W; Li Z; Zhang W
    J Virol; 2024 Jun; 98(6):e0162423. PubMed ID: 38709105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deubiquitinase USP39 promotes SARS-CoV-2 replication by deubiquitinating and stabilizing the envelope protein.
    Chen X; Tian L; Zhang L; Gao W; Yu M; Li Z; Zhang W
    Antiviral Res; 2024 Jan; 221():105790. PubMed ID: 38158131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The E3 Ubiquitin Ligase Ring Finger Protein 5 Ameliorates NASH Through Ubiquitin-Mediated Degradation of 3-Hydroxy-3-Methylglutaryl CoA Reductase Degradation Protein 1.
    Yang Q; Chen X; Zhang Y; Hu S; Hu F; Huang Y; Ma T; Hu H; Tian H; Tian S; Ji YX; She ZG; Zhang P; Zhang XJ; Hu Y; Yang H; Yuan Y; Li H
    Hepatology; 2021 Dec; 74(6):3018-3036. PubMed ID: 34272738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The E3 ligase TRIM22 restricts SARS-CoV-2 replication by promoting proteasomal degradation of NSP8.
    Fan L; Zhou Y; Wei X; Feng W; Guo H; Li Y; Gao X; Zhou J; Wen Y; Wu Y; Shen X; Liu L; Xu G; Zhang Z
    mBio; 2024 Feb; 15(2):e0232023. PubMed ID: 38275298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newcastle Disease Virus V Protein Degrades Mitochondrial Antiviral Signaling Protein To Inhibit Host Type I Interferon Production via E3 Ubiquitin Ligase RNF5.
    Sun Y; Zheng H; Yu S; Ding Y; Wu W; Mao X; Liao Y; Meng C; Ur Rehman Z; Tan L; Song C; Qiu X; Wu F; Ding C
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31270229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of E3 ubiquitin ligases and deubiquitinating enzymes in SARS-CoV-2 infection.
    Zhao M; Zhang M; Yang Z; Zhou Z; Huang J; Zhao B
    Front Cell Infect Microbiol; 2023; 13():1217383. PubMed ID: 37360529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UBR5 Acts as an Antiviral Host Factor against MERS-CoV via Promoting Ubiquitination and Degradation of ORF4b.
    Zhou Y; Zheng R; Liu D; Liu S; Disoma C; Li S; Liao Y; Chen Z; Du A; Dong Z; Zhang Y; Liu P; Razzaq A; Chen D; Chen X; Zhong X; Liu S; Tao S; Liu Y; Xu L; Deng X; Li J; Jiang T; Zhao J; Li S; Xia Z
    J Virol; 2022 Sep; 96(17):e0074122. PubMed ID: 35980206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin Ligase Parkin Regulates the Stability of SARS-CoV-2 Main Protease and Suppresses Viral Replication.
    Zhou L; Liu R; Pathak H; Wang X; Jeong GH; Kumari P; Kumar M; Yin J
    ACS Infect Dis; 2024 Mar; 10(3):879-889. PubMed ID: 38386664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E3 ubiquitin ligase RNF5 attenuates pathological cardiac hypertrophy through STING.
    Yang LL; Xiao WC; Li H; Hao ZY; Liu GZ; Zhang DH; Wu LM; Wang Z; Zhang YQ; Huang Z; Zhang YZ
    Cell Death Dis; 2022 Oct; 13(10):889. PubMed ID: 36270989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1.
    Ma-Lauer Y; Carbajo-Lozoya J; Hein MY; Müller MA; Deng W; Lei J; Meyer B; Kusov Y; von Brunn B; Bairad DR; Hünten S; Drosten C; Hermeking H; Leonhardt H; Mann M; Hilgenfeld R; von Brunn A
    Proc Natl Acad Sci U S A; 2016 Aug; 113(35):E5192-201. PubMed ID: 27519799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of Viral Glycoprotein Targeting by Membrane-Associated RING-CH Proteins.
    Lun CM; Waheed AA; Majadly A; Powell N; Freed EO
    mBio; 2021 Mar; 12(2):. PubMed ID: 33727347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Deubiquitinase USP29 Promotes SARS-CoV-2 Virulence by Preventing Proteasome Degradation of ORF9b.
    Gao W; Wang L; Ju X; Zhao S; Li Z; Su M; Xu J; Wang P; Ding Q; Lv G; Zhang W
    mBio; 2022 Jun; 13(3):e0130022. PubMed ID: 35638730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of HECT E3 ligases as potential therapy for COVID-19.
    Novelli G; Liu J; Biancolella M; Alonzi T; Novelli A; Patten JJ; Cocciadiferro D; Agolini E; Colona VL; Rizzacasa B; Giannini R; Bigio B; Goletti D; Capobianchi MR; Grelli S; Mann J; McKee TD; Cheng K; Amanat F; Krammer F; Guarracino A; Pepe G; Tomino C; Tandjaoui-Lambiotte Y; Uzunhan Y; Tubiana S; Ghosn J; ; ; ; Notarangelo LD; Su HC; Abel L; Cobat A; Elhanan G; Grzymski JJ; Latini A; Sidhu SS; Jain S; Davey RA; Casanova JL; Wei W; Pandolfi PP
    Cell Death Dis; 2021 Mar; 12(4):310. PubMed ID: 33762578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E3 ubiquitin ligase ZBTB25 suppresses beta coronavirus infection through ubiquitination of the main viral protease MPro.
    Lear TB; Boudreau ÁN; Lockwood KC; Chu E; Camarco DP; Cao Q; Nguyen M; Evankovich JW; Finkel T; Liu Y; Chen BB
    J Biol Chem; 2023 Dec; 299(12):105388. PubMed ID: 37890782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A small-molecule inhibitor and degrader of the RNF5 ubiquitin ligase.
    Ruan J; Liang D; Yan W; Zhong Y; Talley DC; Rai G; Tao D; LeClair CA; Simeonov A; Zhang Y; Chen F; Quinney NL; Boyles SE; Cholon DM; Gentzsch M; Henderson MJ; Xue F; Fang S
    Mol Biol Cell; 2022 Nov; 33(13):ar120. PubMed ID: 36074076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNF5: inhibiting antiviral immunity and shaping virus life cycle.
    Ge J; Zhang L
    Front Immunol; 2023; 14():1324516. PubMed ID: 38250078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.